World AIDS day marked by new vaccine progress

GeoVax Labs chose World AIDS day to announce that it is launching a Phase II trial of a new vaccine at 12 sites in collaboration with the NIH and the HIV Vaccine Trials Network. The trial will study the effects of the vaccine on 225 volunteers. GeoVax was spun out of Emory University in 2001. FierceVaccines